切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - FAAH - Topoisomerases - Mcl-1 - 5-HT Transporters

27件产品中的 1-10

页面
每页
清除全部
  1. A-1210477
    B6011 A-1210477
     2 Citation
    Target: Mcl-1
    Summary: MCL-1抑制剂
      insoluble in DMSO
      insoluble in H2O
  2. UMI-77
    B4881 UMI-77
     1 Citation
    Target: Mcl-1
    Summary: Mcl-1抑制剂
      ≥23.4 mg/mL
      insoluble in H2O
  3. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  6. Paroxetine HCl
    B2252 Paroxetine HCl
     1 Citation
    中文名: 盐酸帕罗西汀
    Target: 5-HT Transporters
    Summary: 抗抑郁药
      ≥36.73 mg/mL
      insoluble in H2O
  7. Desvenlafaxine
    B2236 Desvenlafaxine
    中文名: 去甲文拉法辛
    Target: 5-HT Transporters|Norepinephrine transporters
    Summary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
      ≥13.2 mg/mL
  8. Amitriptyline HCl
    B2231 Amitriptyline HCl
    中文名: 盐酸阿米替林
    Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters
    Summary: 血清素/去甲肾上腺素受体/5-HT4/5-HT2抑制剂
      ≥15.69 mg/mL
      ≥43.9 mg/mL
  9. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  10. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL

27件产品中的 1-10

页面
每页